We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Form 483 to Novo Nordisk for Inadequate Sterility Controls
FDA Issues Form 483 to Novo Nordisk for Inadequate Sterility Controls
The FDA slammed Denmark’s Novo Nordisk for numerous GMP issues in a 13-item Form 483 for inadequate controls for sterility, environmental monitoring, labeling and written procedures.